We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$71.6B
AUM Growth
+$8.36B
Cap. Flow
+$5.19B
Cap. Flow %
7.25%
Top 10 Hldgs %
7.9%
Holding
3,652
New
433
Increased
1,585
Reduced
1,146
Closed
462

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$468M
2
JNJ icon
Johnson & Johnson
JNJ
+$440M
3
IBM icon
IBM
IBM
+$355M
4
BKNG icon
Booking.com
BKNG
+$332M
5
RAI
Reynolds American Inc
RAI
+$331M

Sector Composition

Rank Sector Weight
1 Healthcare 15.02%
2 Technology 13.31%
3 Financials 12.25%
4 Industrials 9.65%
5 Consumer Staples 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XMAX
3351
XMAX Inc
XMAX
$594M
-1,682
Closed -$81K
NWG icon
3352
NatWest
NWG
$75.8B
-35,286
Closed -$210K
NWSA icon
3353
News Corp Class A
NWSA
$15.5B
-1,944,300
Closed -$22.3M
OII icon
3354
Oceaneering
OII
$5.05B
-39,600
Closed -$1.12M
OLLI icon
3355
Ollie's Bargain Outlet
OLLI
$4.76B
-33,900
Closed -$964K
OMCL icon
3356
Omnicell
OMCL
$1.68B
-23,243
Closed -$788K
OMF icon
3357
OneMain Financial
OMF
$7.32B
-50,300
Closed -$1.11M
ORC
3358
Orchid Island Capital
ORC
$1.31B
-433,560
Closed -$23.5M
ORCL icon
3359
Oracle
ORCL
$419B
-335,700
Closed -$12.9M
PBF icon
3360
PBF Energy
PBF
$8.22B
-17,500
Closed -$488K
PCAR icon
3361
PACCAR
PCAR
$69.8B
-720,567
Closed -$30.7M
PCRX icon
3362
Pacira BioSciences
PCRX
$972M
-25,200
Closed -$814K
PCTY icon
3363
Paylocity
PCTY
$7.7B
-67,900
Closed -$2.04M
PFE icon
3364
Pfizer
PFE
$152B
-3,000,738
Closed -$92.5M
PFGC icon
3365
Performance Food Group
PFGC
$17.9B
-26,200
Closed -$629K
PHIO icon
3366
Phio Pharmaceuticals
PHIO
$12.7M
-4
Closed -$164K
PLG
3367
Platinum Group Metals
PLG
$194M
-5,398
Closed -$77K
PLUS icon
3368
ePlus
PLUS
$2.32B
-33,200
Closed -$956K
PNFP icon
3369
Pinnacle Financial Partners Inc
PNFP
$16B
-60,992
Closed -$4.23M
PNR icon
3370
Pentair
PNR
$10.7B
-973,901
Closed -$36.7M
PPG icon
3371
PPG Industries
PPG
$25.8B
-253,300
Closed -$24M
PPL
3372
PPL Corp
PPL
$26.5B
-398,200
Closed -$13.6M
PRGO icon
3373
Perrigo
PRGO
$1.78B
-628,508
Closed -$52.3M
PRI icon
3374
Primerica
PRI
$9.63B
-381,999
Closed -$26.4M
PRPO icon
3375
Precipio
PRPO
$39.9M
-43
Closed -$109K

Similar funds

Jim Simons's Q1 2017 Portfolio in Review

As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.

  • Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
  • Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
  • Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
  • Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
  • Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
  • Jim Simons opened 433 new positions and closed 462 in Q1 2017.
  • Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.